Directed evolution of angiotensin-converting enzyme 2 (ACE2) peptidase activity profiles for therapeutic applications
This paper engineers ACE2 variants with enhanced hydrolytic activity and specificity toward Angiotensin-II, improving therapeutic potential for diseases like ARDS and Alzheimer's.
bioRxiv · Jan 3, 2022Biochemistry